Zdrowie i gospodarka · 05/08/1997

FDA Revokes Bio-Components, Inc.'s U.S. License No. 1160 for Source Plasma and Source Leukocytes

The FDA has revoked U.S. License No. 1160, which includes the establishment license and product licenses for Source Plasma and Source Leukocytes, issued to Bio-Components, Inc., following the company's failure to respond to a notice of opportunity for a hearing on a proposal to revoke its licenses.